Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Let's discuss COVID-19 Bivalent Booster Effectiveness - ICAP
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
A quick update on the bivalent boosters - by Eric Topol
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
Why payers should be preparing now for new COVID-19 boosters
New Omicron-specific vaccines offer similar protection to existing boosters
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada | medRxiv
Real-world data show new Covid boosters increase protection
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
A quick update on the bivalent boosters - by Eric Topol
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
Bivalent mRNA booster effective, 'essential' for older adults
DPH Shares Monthly COVID-19 Update, Announces Changes to Data Reporting and Booster Guidance - State of Delaware News
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
New Omicron-specific vaccines offer similar protection to existing boosters
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
